3/25/2010. Age-adjusted incidence rates for coronary heart disease according to body mass index and waist circumference tertiles
|
|
- Brice Owen
- 6 years ago
- Views:
Transcription
1 Outline Relationships among Regional Adiposity, Physical Activity, and CVD Risk Factors: Preliminary Results from Two Epidemiologic Studies Molly Conroy, MD, MPH Obesity Journal Club February 18, 2010 Measuring regional adiposity in epidemiological studies Regional adiposity, physical activity, and cardiometabolic risk factors in the WOMAN study Regional adiposity and subclinical carotid disease in the SAVE study Discussion Measuring regional adiposity in epidemiological studies What is regional adiposity? Regional adiposity is a measure of both the quantity and location of adipose (fat) tissue Many different techniques can measure regional adiposity: MRI > CT >> DXA > skinfold > waist/hip Selection of method depends on research question and budget Why does regional adiposity matter? Measuring Waist Circumference (WC) Fat deposition in certain areas (e.g., around visceral organs) associated with poorer metabolic and cardiovascular outcomes Distribution of body fat is independently associated with the metabolic syndrome in older men and women, particularly among those of normal body weight 1
2 Waist Circumference (WC) Cutoffs WC of > 88 cm (35 inches) for women (or > 102 cm (40 inches) for men) is associated with increased risk of hypertension, diabetes, dyslipidemia, and metabolic syndrome These findings are consistent independent of BMI category In women, cutoff consistent across non- Asian racial/ethnic groups WC in Epidemiological Studies Given (relative) ease of measurement, WC data available in many large epi studies Some large studies (e.g., Nurse s Health, Women s Health) use participant-reported p reported measurement, with decent validity compared to technician-measured values Pearson correlation 0.89 for WC in NHS In NHS, WC independently associated with risk of coronary heart disease Age-adjusted incidence rates for coronary heart disease according to body mass index and waist circumference tertiles Limitations of WC As with any method, correlational findings may not be consistent across all groups In Framingham cohort, WC only associated with CVD in overweight women (Freiberg, et al. Obesity (2008) 16, ) 469) Among normal weight or obese women and men (regardless of BMI category) WC did not appear to substantially add to prediction of CVD WC does not differentiate between types of abdominal fat (i.e., visceral vs. subcutaneous) Rexrode, K. M. et al. JAMA 1998;280: Computed Tomography (CT) to Measure Regional Adiposity CT can obtain images of adipose tissue at waist, which can then be divided into subcompartments Volume of visceral adipose tissue (VAT) usually associated with worse cardiometabolic outcomes CT measurements done in subgroups or larger epi studies (e.g., Framingham, SWAN Heart) 2
3 Prevalence of hypertension (HTN), impaired fasting glucose (IFG), diabetes (DM), and MetS among normal-weight (A), overweight (B), and obese (C) individuals across quartiles of VAT Computed Tomography (CT) to Measure Thigh Adiposity Fox, C. S. et al. Circulation 2007;116:39-48 Thigh Adiposity Also a Predictor of Metabolic Disease Health Aging and Body Composition (Health ABC) Study measured adipose tissue at waist and mid-thigh in a biracial, elderly cohort Higher rates of intermuscular fat (IMAT) and VAT were associated with higher fasting insulin in normal-weight (BMI <25 kg/m2) men (r = 0.24 for IMAT, r = 0.37 for VAT, both P < ) and women (r = 0.20 for intermuscular fat, r = 0.40 for VAT, both P < ) Associations were not found in obese subjects (Goodpaster BH, et al Diabetes Care 2003; 26 (2): ) Limitations of CT Cost Participant burden Does not add info beyond WC/BMI in all studies Radiation dose Estimated range in the lifetime attributable risk of cancer if a 20-year-old woman underwent one of several types of computed tomographic (CT) studies using the distribution in radiation dose Regional adiposity, physical activity, and cardiometabolic risk factors in the WOMAN study Smith-Bindman, R. et al. Arch Intern Med 2009;169:
4 The WOMAN Study Women on the Move through Activity and Nutrition (WOMAN) NHLBI-funded study of a non- pharmacological lifestyle intervention Diet and physical activity to reduce weight subclinical markers of CVD in women aged (PI: L. Kuller) 508 women randomized to an intensive intervention or control group Measures Outcome: CT-measured regional adiposity and muscle strength Primary yp predictors: Physical activity Weight Potential moderator: hormone therapy Measures: Regional adiposity and muscle strength CT used to measure two slices: Abdomen at L4-5 Leg at mid-thigh At each region, adipose tissue can be compartmentalized: subcutaneous, subfascial (deep), visceral or intramuscular Thigh muscle size and attenuation KinCom used to measure leg strength isokinetically Measures: Muscle quality Muscle strength: isokinetic quadriceps strength measured by KinCom Muscle mass: thigh muscle area measured by computed tomography (CT) Muscle quality = strength/area CT Image Analysis CT scans analyzed using Slice-o-Matic computer software in Obesity and Nutrition Research Center Analysis takes approximately 20 minutes per scan (abdominal and thigh slice) 4
5 Results: Participant characteristics at 48 months Results: Regional adiposity and muscle quality at 48 months Age (years) Education: college Race: White Hormone Therapy (HT) Use Weight (lbs) BMI Median PA (MET-hrs/week) N=199; data are means or % % 90% 21% Total abdominal fat (cm 2 ) Subcutaneous abdominal fat (cm 2 ) Visceral abdominal fat (cm 2 ) Total leg fat (cm 2 ) Intramuscular leg fat (cm 2 ) Peak strength (Newton meters) Leg muscle area (cm 2 ) Muscle quality (Newton meters/ cm 2 ) Correlations: PA and Regional adiposity/muscle quality PA Total abdominal Visceral abdominal Intramuscular Muscle strength Muscle area Muscle quality P <0.05; P <0.01; P <0.001 Correlations: PA, Regional adiposity/muscle quality, by HT + HT -HT Total abdominal Visceral abdominal Intramuscular Muscle strength Muscle area Muscle quality P <0.05; P <0.01; P <
6 Additional PA analyses No relationship between consistently high activity at various time points and regional adiposity/muscle quality Higher levels of physical activity do not seem to ameliorate/alter the relationship between higher weight and greater levels of adiposity and poorer muscle quality Possible explanations for low correlation between PA and regional adiposity Less variability of PA than in general population Also less variability in adiposity measures by hormone therapy than expected Limitations of PA measure Further analyses could use pedometer or corridor walk data Weight, adiposity and muscle quality Weight Total abdominal 0.79 Visceral abdominal Intramuscular 0.45 Muscle strength 0.22 Muscle area 0.52 Muscle quality Weight, adiposity and muscle quality Intramuscular adiposity is more strongly correlated with muscle quality (r=-0.27) than other regional adiposity measures or weight Also strongest predictor in multivariable models, although not statistically significant (p=0.12) Regional Adiposity, lipids, and glucose/insulin Gluc Ins HDL TG Total abdominal Visceral abdominal Intramuscular Muscle strength Muscle quality Regional Adiposity and NMR lipids Increased visceral adiposity associated with: More large and medium VLDL More large, medium and small LDL Less large HDL; more small HDL Greater VLDL and VLDL TG size Smaller LDL and HDL size Increased intermuscular adiposity only associated with more large VLDL and greater VLDL size P <0.05; P <0.01; P <
7 CT vs. DXA measures High correlation between DXA and CT measures of trunk/abdominal adiposity (r= ) 0.75) and total leg adiposity (0.85) but lower correlation between DXA and intramuscular adiposity (r=0.26) Intramuscular adiposity more strongly associated with muscle quality than DXA measures Conclusions Impact of physical activity on regional adiposity and muscle quality is not significant after considering body weight Intramuscular adiposity measured by CT is the strongest predictor of muscle quality; higher levels of intramuscular fat were associated with poorer muscle quality DXA measures relate to total leg adiposity on CT, but not intramuscular fat Regional adiposity and subclinical carotid disease in the SAVE study Giang (Suzane) T. Le Helen A. Smith Emma Barinas-Mitchell Kim Sutton-Tyrrell (PI) Kazanna C. Hames Molly B. Conroy The SAVE Study Population: Slow Adverse Vascular Effects (SAVE) study (N=300): mean age 38 (±6) years; mean BMI 33 (±4) kg/m2; 78% women; 83% non-black; Pittsburgh, PA Inclusion Criteria: Age 20-45, BMI kg/m2, Reside in Pittsburgh area, Not pregnant, No hypertension, No diabetes, No known CVD Study Design: Cross-sectional analysis of 2- year, ongoing, clinical trial of a behavioral weight loss intervention Measurements Regional Adiposity: Single-slice CT scans measuring VAT taken at spinal column level L4-L5 and thigh IMAT at 15 cm above upper patellar border Carotid AD and IMT: evaluated by B-mode ultrasound Statistical Analysis Pearson correlation coefficients (rho) determined to examine associations of VAT, IMAT, and BMI with carotid AD and IMT Standardized β coefficients (STB) Derived from multivariable linear regression Used to evaluate relationships between both carotid AD and IMT and regional adiposity while controlling for BMI, age, gender, and race 7
8 Characteristics of SAVE Population Characteristic Mean (SD) Age, y 38 (6) Gender, female 234 (78)* Race, nonblack 248 (82.7)* BMI, kg/m (3.8) Weight, kg 92.0 (14.9) Waist Circumference, cm (11.2) Carotid IMT, mm 0.61 (0.10) Carotid AD, mm 690(053) 6.90 (0.53) Abdominal CT Measurements: Subcutaneous Fat, cm (134.0) Visceral Fat, cm (55.7) Total Fat, cm (141.9) Thigh CT Measurements: Subcutaneous Fat, cm (48.1) IMAT, cm (4.8) Total Fat, cm (49.1) *n (%) Univariable and Multivariable Associations between Measures of Regional Adiposity and Carotid Artery Adventitial Diameter Rho STB 1 STB+ 2 VAT IMAT 0.171* Rho, Pearson Correlation Coefficient; STB, Standardized β Coefficient 1 Multivariable Regression Analysis, adjusted for BMI; 2 Multivariable Regression Analysis, adjusted for BMI, age, gender, and race P< * P<0.05 Univariable and Multivariable Associations between Measures of Regional Adiposity and Carotid Artery Intima-Media Thickness Rho STB 1 STB+ 2 VAT * IMAT Rho, Pearson Correlation Coefficient; STB, Standardized β Coefficient 1 Multivariable Regression Analysis, adjusted for BMI; 2 Multivariable Regression Analysis, adjusted for BMI, age, gender, and race P< * P<0.05 Results Increased VAT was significantly associated with increased AD (rho=0.35; p<0.0001) and IMT (rho=0.24; p<0.0001) IMAT was only significantly associated with AD (rho=0.17; p=0.004) Higher BMI was also significantly associated with increased AD (rho=0.33; p<0.0001) and IMT (rho=0.23; p<0.0001) In both fully adjusted multivariable models, VAT was not significantly related to either AD or IMT Male gender, black race, higher BMI, and increasing age were significant predictors of AD and IMT in fully adjusted models (data not shown) Conclusions SAVE participants with greater VAT, IMAT or higher BMI had greater carotid AD and/or IMT measurements, indicating poorer vascular health VAT remained an independent predictor of carotid AD and IMT after adjusting for BMI, but was not a significant predictor of subclinical carotid disease in either fully adjusted model Further work is needed to determine the utility of regional adiposity measures in predicting CVD in younger populations, as well as tracking how regional adiposity and BMI changes over time relate to CVD development Discussion What is your experience with using regional adiposity measurements? Do you find regional adiposity to be a useful concept/tool for your research population(s)? How do you balance the pros and cons of various methods for your subjects? Other questions? 8
The Metabolic Syndrome Update The Metabolic Syndrome Update. Global Cardiometabolic Risk
The Metabolic Syndrome Update 2018 Marc Cornier, M.D. Professor of Medicine Division of Endocrinology, Metabolism & Diabetes Anschutz Health and Wellness Center University of Colorado School of Medicine
More informationObesity, Metabolic Syndrome, and Diabetes: Making the Connections
Obesity, Metabolic Syndrome, and Diabetes: Making the Connections Alka M. Kanaya, M.D. Associate Professor of Medicine & Epi/Biostats University of California, San Francisco February 26, 21 Roadmap 1.
More informationIs there an association between waist circumference and type 2 diabetes or impaired fasting glucose in US adolescents?
Is there an association between waist circumference and type 2 diabetes or impaired fasting glucose in US adolescents? Meghann M. Moore, RD, CD Masters Thesis Maternal & Child Health Track School of Public
More informationMetabolic Syndrome in Asians
Metabolic Syndrome in Asians Alka Kanaya, MD Asst. Professor of Medicine, UCSF Asian CV Symposium, November 17, 2007 The Metabolic Syndrome Also known as: Syndrome X Insulin Resistance Syndrome The Deadly
More informationUMHS-PUHSC JOINT INSTITUTE
Role of Visceral Adiposity in the Pathogenesis of Non-Alcoholic Fatty Liver Disease in Lean versus Obese Patients: A Comparative Study between Patients at UMHS versus PUHSC Lai WEI and Anna LOK W Zhang,
More informationObesity, Weight Loss and Obstructive Sleep Apnea
Obesity, Weight Loss and Obstructive Sleep Apnea Gary D. Foster, Ph.D. Center for Obesity Research and Education Temple University School of Medicine Overview Sociocultural context Obesity: Prevalence
More informationCardiometabolics in Children or Lipidology for Kids. Stanley J Goldberg MD Diplomate: American Board of Clinical Lipidology Tucson, Az
Cardiometabolics in Children or Lipidology for Kids Stanley J Goldberg MD Diplomate: American Board of Clinical Lipidology Tucson, Az No disclosures for this Presentation Death Risk Approximately 40% of
More informationORIGINAL INVESTIGATION. C-Reactive Protein Concentration and Incident Hypertension in Young Adults
ORIGINAL INVESTIGATION C-Reactive Protein Concentration and Incident Hypertension in Young Adults The CARDIA Study Susan G. Lakoski, MD, MS; David M. Herrington, MD, MHS; David M. Siscovick, MD, MPH; Stephen
More informationThe Metabolic Syndrome Update The Metabolic Syndrome: Overview. Global Cardiometabolic Risk
Update 2013 Marc Cornier, M.D. Associate Professor of Medicine Division of Endocrinology, Metabolism & Diabetes Anschutz Health and Wellness Center University of Colorado School of Medicine Denver Health
More informationWAIST-HEIGHT RATIO : A NEW OBESITY INDEX FOR FILIPINOS?
WAIST-HEIGHT RATIO : A NEW OBESITY INDEX FOR FILIPINOS? Consuelo L. Orense, MSPH, Charmaine A. Duante, RMT, MS Epid.(PH), Ermelita N. Bautista, MPH and Lilibeth P. Dasco, MSAN ABSTRACT The study aimed
More informationDevelopment of the Automated Diagnosis CT Screening System for Visceral Obesity
Review Asian Pacific Journal of Disease Management 2008; 2(2), 31-38 Development of the Automated Diagnosis CT Screening System for Visceral Obesity Toru Nakagawa 1), Syuichiro Yamamoto 1), Masataka Irokawa
More informationMetabolic Syndrome. Bill Roberts, M.D., Ph.D. Professor of Pathology University of Utah
Metabolic Syndrome Bill Roberts, M.D., Ph.D. Professor of Pathology University of Utah Objectives Be able to outline the pathophysiology of the metabolic syndrome Be able to list diagnostic criteria for
More informationCVD Risk Assessment. Michal Vrablík Charles University, Prague Czech Republic
CVD Risk Assessment Michal Vrablík Charles University, Prague Czech Republic What is Risk? A cumulative probability of an event, usually expressed as percentage e.g.: 5 CV events in 00 pts = 5% risk This
More informationLecture 7 Body Composition Lecture 7 1. What is Body Composition? 2. Healthy Body Weight 3. Body Fat Distribution 4. What Affects Weight Gain?
Lecture 7 Body Composition 1 Lecture 7 1. What is Body Composition? 2. Healthy Body Weight 3. Body Fat Distribution 4. What Affects Weight Gain? 2 1 Body Composition Relative amounts of fat and fat-free
More informationMetabolic Syndrome Update The Metabolic Syndrome: Overview. Global Cardiometabolic Risk
Metabolic Syndrome Update 21 Marc Cornier, M.D. Associate Professor of Medicine Division of Endocrinology, Metabolism & Diabetes University of Colorado Denver Denver Health Medical Center The Metabolic
More informationThe association of the total cardiovascular risk and non-invasive markers of atherosclerosis with the extent of coronary artery disease
The association of the total cardiovascular risk and non-invasive markers of atherosclerosis with the extent of coronary artery disease S. Kostic 1, D. Mijalkovic 1, D. Djordjevic 2, T. Savic 2, D. Lovic
More informationLEPTIN AS A NOVEL PREDICTOR OF DEPRESSION IN PATIENTS WITH THE METABOLIC SYNDROME
LEPTIN AS A NOVEL PREDICTOR OF DEPRESSION IN PATIENTS WITH THE METABOLIC SYNDROME Diana A. Chirinos, Ronald Goldberg, Elias Querales-Mago, Miriam Gutt, Judith R. McCalla, Marc Gellman and Neil Schneiderman
More informationThe Metabolic Syndrome: Is It A Valid Concept? YES
The Metabolic Syndrome: Is It A Valid Concept? YES Congress on Diabetes and Cardiometabolic Health Boston, MA April 23, 2013 Edward S Horton, MD Joslin Diabetes Center Harvard Medical School Boston, MA
More informationVisceral adipose tissue and carotid intimamedia thickness in HIV-infected patients undergoing cart: a prospective cohort study
Beires et al. BMC Infectious Diseases (2018) 18:32 DOI 10.1186/s12879-017-2884-9 RESEARCH ARTICLE Visceral adipose tissue and carotid intimamedia thickness in HIV-infected patients undergoing cart: a prospective
More informationRehabilitation and Research Training Center on Secondary Conditions in Individuals with SCI. James S. Krause, PhD
Disclosure The contents of this presentation were developed with support from educational grants from the Department of Education, NIDRR grant numbers H133B090005, H133B970011 and H133G010160. However,
More informationKnow Your Number Aggregate Report Comparison Analysis Between Baseline & Follow-up
Know Your Number Aggregate Report Comparison Analysis Between Baseline & Follow-up... Study Population: 340... Total Population: 500... Time Window of Baseline: 09/01/13 to 12/20/13... Time Window of Follow-up:
More informationNon alcoholic fatty liver disease and atherosclerosis Raul Santos, MD
Non alcoholic fatty liver disease and atherosclerosis Raul Santos, MD Sao Paulo Medical School Hospital Sao Paulo, Brazil Disclosure Honoraria received for consult and/or speaker : Astra Zeneca, Amgen,
More informationRoadmap. Diabetes and the Metabolic Syndrome in the Asian Population. Asian. subgroups 8.9. in U.S. (% of total
Diabetes and the Metabolic Syndrome in the Asian Population Alka Kanaya, MD Associate Professor of Medicine, UCSF Feb 26, 2010 Roadmap 1. Diabetes in Asian Americans Prevalence in the U.S. Risk factors
More informationWhy Do We Treat Obesity? Epidemiology
Why Do We Treat Obesity? Epidemiology Epidemiology of Obesity U.S. Epidemic 2 More than Two Thirds of US Adults Are Overweight or Obese 87.5 NHANES Data US Adults Age 2 Years (Crude Estimate) Population
More informationCardiovascular Disease After Spinal Cord Injury: Achieving Best Practice. Suzanne Groah, MD, MSPH Walter Reed Army Medical Center February 12, 2010
Cardiovascular Disease After Spinal Cord Injury: Achieving Best Practice Suzanne Groah, MD, MSPH Walter Reed Army Medical Center February 12, 2010 CAVEAT LECTOR 2 CVD-related Mortality in Aging SCI GU
More informationWhy Screen at 23? What can YOU do?
Why Screen at 23? Every 1 in 2 Asian American adults has diabetes or prediabetes. More than half of Asian Americans did not know they have type 2 diabetes or prediabetes. Asian Americans can develop diabetes
More informationImpact of Body Mass Index and Metabolic Syndrome on the Characteristics of Coronary Plaques Using Computed Tomography Angiography
Impact of Body Mass Index and Metabolic Syndrome on the Characteristics of Coronary Plaques Using Computed Tomography Angiography Cardiovascular Division, Faculty of Medicine, University of Tsukuba Akira
More informationRisk Factors for Heart Disease
Risk Factors for Heart Disease Risk Factors we cannot change (Age, Gender, Family History) Risk Factors we can change (modifiable) Smoking Blood pressure Cholesterol Diabetes Inactivity Overweight Stress
More informationRelationship of Waist Circumference and Lipid Profile in Children
International Journal of Biomedical Science and Engineering 2015; 3(3): 44-48 Published online May 28, 2015 (http://www.sciencepublishinggroup.com/j/ijbse) doi: 10.11648/j.ijbse.20150303.12 ISSN: 2376-7227
More informationRetrospective Cohort Study for the Evaluation of Life- Style Risk Factors in Developing Metabolic Syndrome under the Estimated Abdominal Circumference
Original Asian Pacific Journal of Disease Management 2007; 1(2), 55-63 Retrospective Cohort Study for the Evaluation of Life- Style Risk Factors in Developing Metabolic Syndrome under the Estimated Abdominal
More informationKnow Your Number Aggregate Report Single Analysis Compared to National Averages
Know Your Number Aggregate Report Single Analysis Compared to National s Client: Study Population: 2242 Population: 3,000 Date Range: 04/20/07-08/08/07 Version of Report: V6.2 Page 2 Study Population Demographics
More informationFat Mass. Baseline. (lbs) (lbs) Composition Trend: Total. Aug 17. Apr 17. May 17. Jun 17. Jul 17. Measured Date
Name Sample Report Birth Date: 00/00/000 Height: 74.0 in. Gender Male Age: 54.7 Input Weight: 165.0 lbs. Body Composition Analysis (BCA) DXA or DEXA is a three component model, which means it quantifies
More informationProfessional Diploma. in Nutrition. Module 1. Lesson 1: Health is Your Wealth EQF Level 5. Professional Diploma
Professional Diploma in Nutrition Module 1 Lesson 1: Health is Your Wealth EQF Level 5 Professional Diploma What is Anthropometry? External measurement of body composition Tells you how much of your weight
More informationPage 1. Disclosures. Background. No disclosures
Population-Based Lipid Screening in the Era of a Childhood Obesity Epidemic: The Importance of Non-HDL Cholesterol Assessment Brian W. McCrindle, Cedric Manlhiot, Don Gibson, Nita Chahal, Helen Wong, Karen
More informationThe Metabolic Syndrome Prof. Jean-Pierre Després
The Metabolic Syndrome 1 Jean-Pierre Després, Ph.D., FAHA, FIAS Quebec Heart and Lung Institute Department of Medicine Université Laval Québec, Canada Reaven s syndrome X Triglycerides HDL cholesterol
More informationRick Fox M.A Health and Wellness Specialist
Metabolic Diseases Rick Fox M.A Health and Wellness Specialist Metabolic Diseases Metabolism is the process your body uses to get or make energy from the food you eat. Food is made up of proteins, carbohydrates
More informationMetabolic Monitoring, Schizophrenia Spectrum Illnesses, & Second Generation Antipsychotics
Metabolic Monitoring, Schizophrenia Spectrum Illnesses, & Second Generation Antipsychotics National Council for Behavioral Health Montefiore Medical Center Northwell Health New York State Office of Mental
More informationSleep Apnea: Vascular and Metabolic Complications
Sleep Apnea: Vascular and Metabolic Complications Vahid Mohsenin, M.D. Professor of Medicine Yale University School of Medicine Director, Yale Center for Sleep Medicine Definitions Apnea: Cessation of
More informationImplementing Type 2 Diabetes Prevention Programmes
Implementing Type 2 Diabetes Prevention Programmes Jaakko Tuomilehto Department of Public Health University of Helsinki Helsinki, Finland FIN-D2D Survey 2004 Prevalence of previously diagnosed and screen-detected
More informationMyths, Heart Disease and the Latino Population. Maria T. Vivaldi MD MGH Women s Heart Health Program. Hispanics constitute 16.3 % of US population!
Myths, Heart Disease and the Latino Population Maria T. Vivaldi MD MGH Women s Heart Health Program Hispanics constitute 16.3 % of US population! 1 LEADING CAUSES OF DEATH IN LATINOS Heart disease is the
More informationProf. Samir Morcos Rafla Alexandria Univ. Cardiology Dept.
Obesity as a risk factor for Atrial Fibrillation Prof. Samir Morcos Rafla Alexandria Univ. Cardiology Dept. CardioAlex 2010 smrafla@hotmail.com 1 Obesity has reached epidemic proportions in the United
More informationLDL cholesterol (p = 0.40). However, higher levels of HDL cholesterol (> or =1.5 mmol/l [60 mg/dl]) were associated with less progression of CAC
Am J Cardiol (2004);94:729-32 Relation of degree of physical activity to coronary artery calcium score in asymptomatic individuals with multiple metabolic risk factors M. Y. Desai, et al. Ciccarone Preventive
More informationEdward Melanson, Ph.D., Associate Professor, Division of Endocrinology, Metabolism, and Diabetes University of Colorado Denver
Edward Melanson, Ph.D., Associate Professor, Division of Endocrinology, Metabolism, and Diabetes University of Colorado Denver 45 y/o man Medications: none Social Hx: moderate alcohol intake (1-2 cans
More informationMetabolic Syndrome: A Preventable & Treatable Cluster of Conditions
Metabolic Syndrome: A Preventable & Treatable Cluster of Conditions April D. McNeill MD Candidate 2016, Southern Illinois University, School of Medicine GE-NMF Primary Care Leadership Program, July 2013
More informationQuadriceps Muscle and Intermuscular Fat Volumes in the Thighs of Men in the OAI are Associated with Physical Function and Knee Pain
Quadriceps Muscle and Intermuscular Fat Volumes in the Thighs of Men in the OAI are Associated with Physical Function and Knee Pain Karen A. Beattie, Monica R. Maly, Sami Shaker, Norma J. MacIntyre McMaster
More informationAUTONOMIC FUNCTION IS A HIGH PRIORITY
AUTONOMIC FUNCTION IS A HIGH PRIORITY 1 Bladder-Bowel-AD Tetraplegia Sexual function Walking Bladder-Bowel-AD Paraplegia Sexual function Walking 0 10 20 30 40 50 Percentage of respondents an ailment not
More informationLecture 7 Body Composition Lecture 7 1. What is Body Composition? 2. Healthy Body Weight 3. Body Fat Distribution 4. What Affects Weight Gain?
Lecture 7 Body Composition 1 Lecture 7 1. What is Body Composition? 2. Healthy Body Weight 3. Body Fat Distribution 4. What Affects Weight Gain? 2 1 Body Composition Relative amounts of fat and fat-free
More informationDr Aftab Ahmad Consultant Diabetologist at Royal Liverpool University Hospital Regional Diabetes Network Lead
Dr Aftab Ahmad Consultant Diabetologist at Royal Liverpool University Hospital Regional Diabetes Network Lead Today s Presentation HbA1c & diagnosing Diabetes What is Impaired Glucose & IGR? Implications
More informationI have nothing to disclose.
I have nothing to disclose. Epicardial vs Pericardial Fat? Implications of this Question Thomas H Marwick MBBS, PhD, MPH Menzies Research Institute, Hobart, Australia Epicardial and pericardial fat 1.
More informationOBESITY IN PRIMARY CARE
OBESITY IN PRIMARY CARE Obesity- definition Is a chronic disease In ICD 10 E66 Overweight and obesity are defined as abnormal or excessive fat accumulation that may impair health. Obesity is a leading
More informationClient Report Screening Program Results For: Missouri Western State University October 28, 2013
Client Report For: Missouri Western State University October 28, 2013 Executive Summary PROGRAM OVERVIEW From 1/1/2013-9/30/2013, Missouri Western State University participants participated in a screening
More informationFigure S1. Comparison of fasting plasma lipoprotein levels between males (n=108) and females (n=130). Box plots represent the quartiles distribution
Figure S1. Comparison of fasting plasma lipoprotein levels between males (n=108) and females (n=130). Box plots represent the quartiles distribution of A: total cholesterol (TC); B: low-density lipoprotein
More informationMetabolic Syndrome: An overview. Kevin Niswender MD, PhD Vanderbilt University School of Medicine
Metabolic Syndrome: An overview. Kevin Niswender MD, PhD Vanderbilt University School of Medicine Setting the scene GB, 43 yo AA man followed for hypothyroidism returns on LT4 125 mcg/d and has a TSH=1.1
More informationAssociation between arterial stiffness and cardiovascular risk factors in a pediatric population
+ Association between arterial stiffness and cardiovascular risk factors in a pediatric population Maria Perticone Department of Experimental and Clinical Medicine University Magna Graecia of Catanzaro
More information1. Which one of the following patients does not need to be screened for hyperlipidemia:
Questions: 1. Which one of the following patients does not need to be screened for hyperlipidemia: a) Diabetes mellitus b) Hypertension c) Family history of premature coronary disease (first degree relatives:
More informationChapter 17: Body Composition Status and Assessment
Chapter 17: Body Composition Status and Assessment American College of Sports Medicine. (2010). ACSM's resource manual for guidelines for exercise testing and prescription (6th ed.). New York: Lippincott,
More informationTable S1. Characteristics associated with frequency of nut consumption (full entire sample; Nn=4,416).
Table S1. Characteristics associated with frequency of nut (full entire sample; Nn=4,416). Daily nut Nn= 212 Weekly nut Nn= 487 Monthly nut Nn= 1,276 Infrequent or never nut Nn= 2,441 Sex; n (%) men 52
More informationFlatter Diurnal Cortisol Slope on Workdays is Associated with Pre-clinical Atherosclerosis
Flatter Diurnal Cortisol Slope on Workdays is Associated with Pre-clinical Atherosclerosis Karissa G. Miller, B.A., Thomas W. Kamarck, Ph.D., Matthew F. Muldoon, M.D., Peter J. Gianaros, Ph.D., & Stephen
More informationCARDIOVASCULAR RISK FACTORS & TARGET ORGAN DAMAGE IN GREEK HYPERTENSIVES
CARDIOVASCULAR RISK FACTORS & TARGET ORGAN DAMAGE IN GREEK HYPERTENSIVES C. Liakos, 1 G. Vyssoulis, 1 E. Karpanou, 2 S-M. Kyvelou, 1 V. Tzamou, 1 A. Michaelides, 1 A. Triantafyllou, 1 P. Spanos, 1 C. Stefanadis
More informationModule 2: Metabolic Syndrome & Sarcopenia. Lori Kennedy Inc & Beyond
Module 2: Metabolic Syndrome & Sarcopenia 1 What You Will Learn Sarcopenia Metabolic Syndrome 2 Sarcopenia Term utilized to define the loss of muscle mass and strength that occurs with aging Progressive
More informationThe Reduced Obese State: The Challenge of Weight Maintenance 2011 Annual CAN Conference November 17, 2011
The Reduced Obese State: The Challenge of Weight Maintenance 2011 Annual CAN Conference November 17, 2011 Robert H. Eckel, M.D. Professor of Medicine Professor of Physiology and Biophysics Charles A. Boettcher
More informationCHAPTER 9. Anthropometry and Body Composition
CHAPTER 9 Anthropometry and Body Composition 9.1 INTRODUCTION Ageing is characterized by reduction in fat free mass (FFM), primarily via loss of muscle mass, loss of bone mineral in women, redistribution
More informationCHAPTER 3 DIABETES MELLITUS, OBESITY, HYPERTENSION AND DYSLIPIDEMIA IN ADULT CENTRAL KERALA POPULATION
CHAPTER 3 DIABETES MELLITUS, OBESITY, HYPERTENSION AND DYSLIPIDEMIA IN ADULT CENTRAL KERALA POPULATION 3.1 BACKGROUND Diabetes mellitus (DM) and impaired glucose tolerance (IGT) have reached epidemic proportions
More informationCoronary artery disease (CAD) risk factors
Background Coronary artery disease (CAD) risk factors CAD Risk factors Hypertension Insulin resistance /diabetes Dyslipidemia Smoking /Obesity Male gender/ Old age Atherosclerosis Arterial stiffness precedes
More informationSociety for Behavioral Medicine 33 rd Annual Meeting New Orleans, LA
Society for Behavioral Medicine 33 rd Annual Meeting New Orleans, LA John M. Violanti, PhD* a ; LuendaE. Charles, PhD, MPH b ; JaK. Gu, MSPH b ; Cecil M. Burchfiel, PhD, MPH b ; Michael E. Andrew, PhD
More informationEstablished Risk Factors for Coronary Heart Disease (CHD)
Getting Patients to Make Small Lifestyle Changes That Result in SIGNIFICANT Improvements in Health - Prevention of Diabetes and Obesity for Better Health Maureen E. Mays, MD, MS, FACC Director ~ Portland
More informationPIEDMONT ACCESS TO HEALTH SERVICES, INC. Guidelines for Screening and Management of Dyslipidemia
PIEDMONT ACCESS TO HEALTH SERVICES, INC. Policy Number: 01-09-021 SUBJECT: Guidelines for Screening and Management of Dyslipidemia EFFECTIVE DATE: 04/2008 REVIEWED/REVISED: 04/12/10, 03/17/2011, 4/10/2012,
More informationAutonomic nervous system, inflammation and preclinical carotid atherosclerosis in depressed subjects with coronary risk factors
Autonomic nervous system, inflammation and preclinical carotid atherosclerosis in depressed subjects with coronary risk factors Carmine Pizzi 1 ; Lamberto Manzoli 2, Stefano Mancini 3 ; Gigliola Bedetti
More informationStatistical Fact Sheet Populations
Statistical Fact Sheet Populations At-a-Glance Summary Tables Men and Cardiovascular Diseases Mexican- American Males Diseases and Risk Factors Total Population Total Males White Males Black Males Total
More informationGDF-15 levels but not NTproBNP levels predict diastolic heart failure in morbid obesity
GDF-15 levels but not NTproBNP levels predict diastolic heart failure in morbid obesity M. Fischer, C. Strack, J. Bruxmeier, F. Wagner, E. Rousseva, G. Schmitz, G. Riegger, A. Baessler Clinic for Internal
More informationRELATIONSHIP OF CLINICAL FACTORS WITH ADIPONECTIN AND LEPTIN IN CHILDREN WITH NEWLY DIAGNOSED TYPE 1 DIABETES. Yuan Gu
RELATIONSHIP OF CLINICAL FACTORS WITH ADIPONECTIN AND LEPTIN IN CHILDREN WITH NEWLY DIAGNOSED TYPE 1 DIABETES by Yuan Gu BE, Nanjing Institute of Technology, China, 2006 ME, University of Shanghai for
More informationFat Accumulation and Obesity-related Cardiovascular Risk Factors in Middle-aged Japanese Men and Women
ORIGINAL ARTICLE Fat Accumulation and Obesity-related Cardiovascular Risk Factors in Middle-aged Japanese Men and Women Miwa Ryo 1, Tohru Funahashi 1, Tadashi Nakamura 1, Shinji Kihara 1, Kazuaki Kotani
More informationImpact of Exercise on Patients with Diabetes Mellitus
Impact of Exercise on Patients with Diabetes Mellitus Bret Goodpaster, Ph.D. Exercise Physiologist Assistant Professor of Medicine University of Pittsburgh Division of Endocrinology and Metabolism Learning
More informationSupplemental Table 1: Demographics and characteristics of study participants. Male, n (%) 3 (20%) 6 (50%) Age, years [mean ± SD] 33.3 ± ± 9.
SUPPLEMENTAL DATA Supplemental Table 1: Demographics and characteristics of study participants Lean (n=15) Obese (n=12) Male, n (%) 3 (20%) 6 (50%) Age, years [mean ± SD] 33.3 ± 9.5 44.8 ± 9.1 White, n
More information2010 ADA Guidelines: 1. Diagnostic Criteria for DM 2. Categories of increased risk of DM. Gerti Tashko, M.D. DM Journal Club 1/21/2010
2010 ADA Guidelines: 1. Diagnostic Criteria for DM 2. Categories of increased risk of DM Gerti Tashko, M.D. DM Journal Club 1/21/2010 NEW: Diagnosis with A1c 6.5% Cut point of A1c 6.5% diagnoses 33% less
More informationPresenter Disclosure Information Karine Sahakyan, MD, PhD, MPH
Presenter Disclosure Information Karine Sahakyan, MD, PhD, MPH Disclosed no conflict of interest Normal-weight central obesity and cardiovascular mortality risk in the US population K. Sahakyan, VK. Somers,
More informationClinical Trial Synopsis TL-OPI-518, NCT#
Clinical Trial Synopsis, NCT# 00225264 Title of Study: A Double-Blind, Randomized, Comparator-Controlled Study in Subjects With Type 2 Diabetes Mellitus Comparing the Effects of Pioglitazone HCl vs Glimepiride
More informationObesity in South Korea
Obesity in South Korea Nah-Mee Shin, Ph.D, Assistant Professor, APRN, BC (Nurse Practitioner) Korea University, College of Nursing 1 To get to know South Korea Geography: area: 98,477 sq.km. (38,022 sq.mi.);
More informationASSOCIATIONS BETWEEN C-REACTIVE PROTEIN, PHYSICAL ACTIVITY, AND OTHER CARDIAC RISK FACTORS IN POSTMENOPAUSAL WOMEN. Beth M.
ASSOCIATIONS BETWEEN C-REACTIVE PROTEIN, PHYSICAL ACTIVITY, AND OTHER CARDIAC RISK FACTORS IN POSTMENOPAUSAL WOMEN by Beth M. Larouere BS Degree Physical Education- Exercise Science, Slippery Rock University,
More informationNOT-FED Study New Obesity Treatment- Fasting, Exercise, Diet
NOT-FED Study New Obesity Treatment- Fasting, Exercise, Diet FASTING 16 hours a day EXCERCISE 150 min a week DIET Low carb NOSM Northern Research Conference, Kenora, 2018 R Minty, T O Driscoll, L Kelly,
More informationEndocrine Update Mary T. Korytkowski MD Division of Endocrinology University of Pittsburgh
Endocrine Update 2016 Mary T. Korytkowski MD Division of Endocrinology University of Pittsburgh Disclosure of Financial Relationships Mary Korytkowski MD Honoraria British Medical Journal Diabetes Research
More informationReport Operation Heart to Heart
Report Operation Heart to Heart Elkhorn Logan Valley Public Health Department (Burt, Cuming, Madison, and Stanton Counties) Gina Uhing, Health Director Ionia Research Newcastle, Nebraska Joseph Nitzke
More informationWeighing in on Whole Grains: A review of Evidence Linking Whole Grains to Body Weight. Nicola M. McKeown, PhD Scientist II
Weighing in on Whole Grains: A review of Evidence Linking Whole Grains to Body Weight Nicola M. McKeown, PhD Scientist II Weighing in on Whole Grains: A review of Evidence Linking Whole Grains to Body
More informationSupplementary Table 1. Association of rs with risk of obesity among participants in NHS and HPFS
Supplementary Table 1. Association of rs3826795 with risk of obesity among participants in NHS and HPFS Case/control NHS (1990) HPFS (1996) OR (95% CI) P- value Case/control OR (95% CI) P- value Obesity
More informationORIGINAL ARTICLE. Abstract. Introduction
ORIGINAL ARTICLE Health Education Hokenshido Program Reduced Metabolic Syndrome in the Amagasaki Visceral Fat Study. Three-Year Follow-up Study of 3,174 Japanese Employees Miwa Ryo 1, Tadashi Nakamura
More informationOptimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden
Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden Cardiovascular Disease Prevention (CVD) Three Strategies for CVD
More informationMetabolically healthy obesity and NAFLD
News & Views Metabolically healthy obesity and NAFLD Giovanni Targher and Christopher D. Byrne Giovanni Targher is at the Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University
More informationABSTRACT. Dr. Jiuzhou Song, Department of Avian and Animal Sciences. Blacks in the country suffer from higher prevalences of obesity, diabetes,
ABSTRACT Title of Document: IS THE CURRENT DEFINITION OF THE METABOLIC SYNDROME A USEFUL TOOL FOR THE DETECTION OF CARDIOVASCULAR DISEASE IN NON- HISPANIC BLACKS? Omayra I. Rodriguez, Masters in Science,
More informationFat redistribution on ARVs: dogma versus data
Fat redistribution on ARVs: dogma versus data Gary Maartens Division of Clinical Pharmacology UNIVERSITY OF CAPE TOWN IYUNIVESITHI YASEKAPA UNIVERSITEIT VAN KAAPSTAD Half of what we are going to teach
More informationPrevalence of Comorbidities among HIV-positive patients in Taiwan
Prevalence of Comorbidities among HIV-positive patients in Taiwan Chien-Ching Hung, MD, PhD Department of Internal Medicine National Taiwan University Hospital, Taipei, Taiwan % of participants Comorbidity
More informationAdult BMI Calculator
For more information go to Center for Disease Control http://search.cdc.gov/search?query=bmi+adult&utf8=%e2%9c%93&affiliate=cdc-main\ About BMI for Adults Adult BMI Calculator On this page: What is BMI?
More informationReview of guidelines for management of dyslipidemia in diabetic patients
2012 international Conference on Diabetes and metabolism (ICDM) Review of guidelines for management of dyslipidemia in diabetic patients Nan Hee Kim, MD, PhD Department of Internal Medicine, Korea University
More informationDiabetes and Heart Disease. Sarah Alexander, MD, FACC Assistant Professor of Medicine Rush University Medical Center
Diabetes and Heart Disease Sarah Alexander, MD, FACC Assistant Professor of Medicine Rush University Medical Center No conflicts of interest or financial relationships to disclose. 2 What s the problem??
More informationKathryn M. Rexrode, MD, MPH. Assistant Professor. Division of Preventive Medicine Brigham and Women s s Hospital Harvard Medical School
Update: Hormones and Cardiovascular Disease in Women Kathryn M. Rexrode, MD, MPH Assistant Professor Division of Preventive Medicine Brigham and Women s s Hospital Harvard Medical School Overview Review
More informationObesity D R. A I S H A H A L I E K H Z A I M Y
Obesity D R. A I S H A H A L I E K H Z A I M Y Objectives Definition Pathogenesis of obesity Factors predisposing to obesity Complications of obesity Assessment and screening of obesity Management of obesity
More informationJoslin Diabetes Center Primary Care Congress for Cardiometabolic Health 2013 The Metabolic Syndrome: Is It a Valid Concept?
The Metabolic Syndrome: A Defeated Emperor What were (are) the problems? Well 1. There was no agreed upon pathogenic reason to identify people with the metabolic syndrome 2. It was a relatively poor way
More informationPre-diabetes. Pharmacological Approaches to Delay Progression to Diabetes
Pre-diabetes Pharmacological Approaches to Delay Progression to Diabetes Overview Definition of Pre-diabetes Risk Factors for Pre-diabetes Clinical practice guidelines for diabetes Management, including
More information3/20/2011. Body Mass Index (kg/[m 2 ]) Age at Issue (*BMI > 30, or ~ 30 lbs overweight for 5 4 woman) Mokdad A.H.
U.S. Adults: 1988 Nineteen states with 10-14% 14% Prevalence of Obesity (*BMI > 30, or ~ 30 lbs overweight for 5 4 woman) Metabolic John P. Cello, MD Professor of Medicine and Surgery, University of California,
More informationObesity, metabolic dysfunction, and the risk of obesity-related cancer
Boston University OpenBU Theses & Dissertations http://open.bu.edu Boston University Theses & Dissertations 2016 Obesity, metabolic dysfunction, and the risk of obesity-related cancer Chadid, Susan https://hdl.handle.net/2144/16734
More informationTiming and tempo of first year growth in relation to cardiovascular and metabolic risk profile in early adulthood
Note: for non-commercial purposes only Timing and tempo of first year growth in relation to cardiovascular and metabolic risk profile in early adulthood Anita Hokken-Koelega Professor of Pediatric Endocrinology
More information